SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
20562589
Source:
http://linkedlifedata.com/resource/pubmed/id/20562589
Search
Subject
(
59
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0040808
,
umls-concept:C0546837
,
umls-concept:C0596545
,
umls-concept:C1559154
pubmed:issue
4
pubmed:dateCreated
2011-7-27
pubmed:abstractText
The aim of this study was to retrospectively evaluate toxicity and efficacy of 3 chemoradiation regimens.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8207754
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Carboplatin
,
http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin
,
http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil
,
http://linkedlifedata.com/resource/pubmed/chemical/Paclitaxel
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1537-453X
pubmed:author
pubmed-author:AlemanBerthe M PBM
,
pubmed-author:BootHenkH
,
pubmed-author:CatsAnnemiekeA
,
pubmed-author:Courrech StaalEwout F WEF
,
pubmed-author:JansenEdwin P MEP
,
pubmed-author:van CoevordenFritsF
,
pubmed-author:van SandickJohanna WJW
,
pubmed-author:van VelthuysenMarie-Louise FML
pubmed:issnType
Electronic
pubmed:volume
34
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
343-9
pubmed:meshHeading
pubmed-meshheading:20562589-Adenocarcinoma
,
pubmed-meshheading:20562589-Adult
,
pubmed-meshheading:20562589-Aged
,
pubmed-meshheading:20562589-Aged, 80 and over
,
pubmed-meshheading:20562589-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:20562589-Carboplatin
,
pubmed-meshheading:20562589-Carcinoma, Squamous Cell
,
pubmed-meshheading:20562589-Cisplatin
,
pubmed-meshheading:20562589-Cohort Studies
,
pubmed-meshheading:20562589-Combined Modality Therapy
,
pubmed-meshheading:20562589-Esophageal Neoplasms
,
pubmed-meshheading:20562589-Female
,
pubmed-meshheading:20562589-Fluorouracil
,
pubmed-meshheading:20562589-Follow-Up Studies
,
pubmed-meshheading:20562589-Humans
,
pubmed-meshheading:20562589-Male
,
pubmed-meshheading:20562589-Middle Aged
,
pubmed-meshheading:20562589-Neoadjuvant Therapy
,
pubmed-meshheading:20562589-Paclitaxel
,
pubmed-meshheading:20562589-Radiotherapy
,
pubmed-meshheading:20562589-Remission Induction
,
pubmed-meshheading:20562589-Retrospective Studies
,
pubmed-meshheading:20562589-Survival Rate
,
pubmed-meshheading:20562589-Treatment Outcome
pubmed:year
2011
pubmed:articleTitle
Chemoradiation for esophageal cancer: institutional experience with three different regimens.
pubmed:affiliation
Department of Surgical Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. e.courrech@nki.nl
pubmed:publicationType
Journal Article